NASHVILLE, Tenn.–(BUSINESS WIRE)–Aegis Sciences Corporation, a health care testing lab based in Nashville, Tenn., is pleased to announce it will be updating their urine testing for marijuana and other cannabinoids to include Delta‐8 Carboxy‐THC and Cannabidiol, in addition to Delta‐9 Carboxy‐THC.
Delta‐8 and delta‐9 THC are psychoactive cannabinoids that are subject to variable state and federal regulations. Cannabidiol is also a naturally occurring cannabinoid but is not known to be psychoactive. These cannabinoids are naturally occurring and can be found in many different products including liquids used for electronic cigarettes (i.e., vapes) edibles, and drinks. Concentrations of these cannabinoids, when detected in urine, do not definitively indicate source of substance used or exposure that contributed to positive findings and will not be reported with interpretative differentiations. The interpretation of marijuana results differs when considering presumptive vs definitive testing. Aegis’s assay will continue to undergo presumptive testing by immunoassay with reflex to definitive testing by mass spectrometry. Results of positive findings for each analyte will be reported individually.
“Expanding our marijuana assay to include other cannabinoids demonstrates our commitment to providing the most relevant testing available to healthcare providers,” said Dr. Rebecca Heltsley, Senior Vice President, Research and Development at Aegis Sciences Corporation.
Health care practitioners can learn more about the updated test offering through the Aegis website: https://www.aegislabs.com.
About Aegis Sciences Corporation
Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, Tenn., that provides science-driven testing and consulting services for clients such as health care providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information, please visit http://www.aegislabs.com/.
Contacts
Stephanie Protz
Manager, Marketing Communications
Aegis Sciences Corporation
[email protected]
